180 Life Sciences Corp. (NASDAQ: ATNF)
$2.08
-0.0500 ( -2.35% ) 128.5K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$2.08
Previous close
$2.13
Volume
128.5K
Market cap
$1.91M
Day range
$2.00 - $2.28
52 week range
$1.31 - $21.28
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 06, 2023 |
| 4 | Insider transactions | 1 | Sep 06, 2023 |
| 4 | Insider transactions | 1 | Sep 06, 2023 |
| 8-k | 8K-related | 19 | Aug 15, 2023 |
| 10-q | Quarterly Reports | 60 | Aug 15, 2023 |
| nt | Quarterly Reports | 1 | Aug 14, 2023 |
| 8-k | 8K-related | 14 | Aug 07, 2023 |
| 8-k | 8K-related | 14 | Aug 03, 2023 |
| 8-k | 8K-related | 14 | Jul 31, 2023 |
| 8-k | 8K-related | 15 | Jul 10, 2023 |